Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
4.000
+0.290 (7.82%)
Nov 4, 2024, 4:00 PM EST - Market closed
Cabaletta Bio Stock Forecast
CABA's stock price has decreased by -75% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Cabaletta Bio stock have an average target of 29.3, with a low estimate of 10 and a high estimate of 50. The average target predicts an increase of 632.50% from the current stock price of 4.00.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Cabaletta Bio stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 4 | 5 |
| Buy | 3 | 4 | 4 | 5 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 9 | 10 | 9 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +150.00% | Oct 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +525.00% | Sep 17, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $35 → $20 | Buy | Maintains | $35 → $20 | +400.00% | Aug 12, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $25 → $15 | Buy | Maintains | $25 → $15 | +275.00% | Aug 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $25 | Strong Buy | Maintains | $30 → $25 | +525.00% | Aug 9, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.28
from -1.65
EPS Next Year
-2.45
from -2.28
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 15.8M | ||
| Avg | n/a | n/a | 2.2M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.12 | -1.53 | -1.58 | ||
| Avg | -2.28 | -2.45 | -2.51 | ||
| Low | -2.34 | -2.90 | -3.19 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.